arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Progyny, Inc.

PGNY
$28.11 ▼ -2.09 (-6.90%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
34 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
69
Health
Good
Neutral
auto_awesome

Analytical Summary

Progyny, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $2.3B
Dividend Yield
Revenue Growth 1.4%
Op. Margin 10.8%
ROIC 5.3%
FCF / Share $0.49
Trailing P/E 93.7x
Price / Book 5.0x
FCF Yield 1.7%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

34-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$328.50M
↑ +1.4%
Net Income Profit after all expenses
$24.23M
↑ +60.9%
Operating Margin Operating profit as % of sales
10.8%
↑ +125.3% 47th
FCF / Share Free cash flow per share
$0.49
↓ -10.9%

Health Breakdown

Profitability
56
Returns
72
Cash Quality
92

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters